{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:54Z","timestamp":1790985294397,"version":"4.1.0"},"reference-count":0,"publisher":"Archives of Endocrinology and Metabolism","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["A&EM"],"published-print":{"date-parts":[[2025]]},"DOI":"10.20945\/2359-4292-2025-0127","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:59:51Z","timestamp":1761922791000},"page":"1-8","source":"Crossref","is-referenced-by-count":3,"title":["BRAF inhibitor or BRAF\/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer"],"prefix":"10.20945","volume":"69","author":[{"given":"Inbar","family":"Finkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Korzets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Coreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Popovtzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Shoffel-Havakuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Bachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobran","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chana","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Robenshtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","published-online":{"date-parts":[[2025]]},"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.aem-sbem.com\/article\/braf-inhibitor-or-braf-mek-inhibitor-treatment-for-patients-with-metastatic-braf-v600e-mutated-differentiated-thyroid-cancer\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:59:52Z","timestamp":1761922792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/braf-inhibitor-or-braf-mek-inhibitor-treatment-for-patients-with-metastatic-braf-v600e-mutated-differentiated-thyroid-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2025-0127","relation":{},"ISSN":["2359-3997"],"issn-type":[{"value":"2359-3997","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}